# Immune Repertoire of Ovarian HGSC

> **NCT03794115** · — · UNKNOWN · sponsor: **Lei Li** · enrollment: 40 (estimated)

## Conditions studied

- Ovarian High Grade Serous Carcinoma
- Immune Repertoire
- T Lymphocyte Receptor
- B Lymphocyte Receptor

## Interventions

- **PROCEDURE:** Treatment for ovarian cancer

## Key facts

- **NCT ID:** NCT03794115
- **Lead sponsor:** Lei Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-03
- **Primary completion:** 2021-01-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03794115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03794115, "Immune Repertoire of Ovarian HGSC". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03794115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*